Atria reported Q2 adjusted EBIT of EUR 13.8m, up from EUR 12.
Q2 in line with expectations, estimates intact Strong M&A pipeline and balance sheet 8x EV/EBIT, att...
Q2 report overshadowed by Kölvallen divestment Kölvallen to add SEK 690m to Q3 Value range at SEK 80...
Q2 report due on Wednesday, 17 August Fewer newbuilds could be a headwind for FW in ’23e NWT ramp-up...
Q2 sales growth of 12.4% (2.8% organic) Sales estimates up ~1%, albeit with a lower EBIT margin New ...
Q2 report due on Wednesday, 17 August Strong production volumes, sampling cups decline y-o-y Full or...
God tillväxt men svagare marginal Justerad nettoomsättning i Q2 uppgick till 190 mkr (130 mkr Q2'21)...
Starka siffror genom hela rapporten.... Omsättningen i kvartalet uppgick till 31,1 mkr vs vårt estim...
Old projects marked off – positive Likely a net seller in the coming quarters We trim rental income...
Redeye will likely make minor forecast adjustments following Hoylu’s Q2’22 report revealed earlier t...
Q2 fairly in line with our expectations Estimates intact on isolated numbers 8.
Atria reported Q2 adjusted EBIT of EUR 13.8m versus our estimate of EUR 2.
Redeye retains its positive view on Lagercrantz following a solid Q1 report with 9% organic growth a...
Redeye retains its positive view on Formpipe following a solid Q2 report with strong ACV and positiv...
Redeye raises its forecasts and Base Case for Addnode following a solid Q2 beating our estimates, mo...
Sales 13% y-o-y but 4% below ABGSCe Several new growth initiatives result in EBIT cuts 15x-11x ‘22e-...
43% sales growth y-o-y, 37% organic We raise ’23e sales & EBIT estimates by 6% and 10% New fair valu...
4% sales miss, mainly due to lower license sales We cut our EBIT estimates on higher costs We contin...
Organic growth down to 4-6% (cons. 6.2%) EBITDA down to 18-20% (cons.
Redeye is impressed with Arise’s sale of Kölvallen, with an expected EBITDA contribution of about EU...
